Cargando…
Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308183/ https://www.ncbi.nlm.nih.gov/pubmed/34318049 http://dx.doi.org/10.1016/j.xjtc.2020.10.046 |
| _version_ | 1783728220203384832 |
|---|---|
| author | Carrel, Thierry |
| author_facet | Carrel, Thierry |
| author_sort | Carrel, Thierry |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8308183 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83081832021-07-26 Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines? Carrel, Thierry JTCVS Tech Commentary Elsevier 2020-11-17 /pmc/articles/PMC8308183/ /pubmed/34318049 http://dx.doi.org/10.1016/j.xjtc.2020.10.046 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Carrel, Thierry Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines? |
| title | Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines? |
| title_full | Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines? |
| title_fullStr | Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines? |
| title_full_unstemmed | Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines? |
| title_short | Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines? |
| title_sort | commentary: endocarditis in hypertrophic cardiomyopathy: a reason to strengthen the guidelines? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308183/ https://www.ncbi.nlm.nih.gov/pubmed/34318049 http://dx.doi.org/10.1016/j.xjtc.2020.10.046 |
| work_keys_str_mv | AT carrelthierry commentaryendocarditisinhypertrophiccardiomyopathyareasontostrengthentheguidelines |